Skip to main content
Erschienen in: Cardiovascular Drugs and Therapy 3/2013

01.06.2013 | ORIGINAL ARTICLE

Lack of Effect of Nitrates on Exercise Stress Test Results in Patients with Microvascular Angina

verfasst von: Giulio Russo, Antonino Di Franco, Priscilla Lamendola, Pierpaolo Tarzia, Roberto Nerla, Alessandra Stazi, Angelo Villano, Alfonso Sestito, Gaetano A. Lanza, Filippo Crea

Erschienen in: Cardiovascular Drugs and Therapy | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To assess the effects of short-acting nitrates on exercise stress test (EST) results and the relation between EST results and coronary blood flow (CBF) response to nitrates in patients with microvascular angina (MVA).

Methods

We completed 2 symptom/sign limited ESTs on 2 separate days, in a random sequence and in pharmacological washout, in 29 MVA patients and in 24 patients with obstructive coronary artery disease (CAD): one EST was performed without any intervention (control EST, C-EST), and the other after sublingual isosorbide dinitrate, 5 mg (nitrate EST, N-EST). CBF response to nitroglycerin (25 μg) was assessed in the left anterior descending coronary artery by transthoracic Doppler-echocardiography.

Results

At C-EST. ST-segment depression ≥1 mm (STD) was induced in 26 (90 %) and 23 (96 %) MVA and CAD patients, respectively (p = 0.42), whereas at N-EST, STD was induced in 25 (86 %) and 14 (56 %) MVA and CAD patients, respectively (p = 0.01). Time and rate pressure product at 1 mm STD increased during N-EST, compared to C-EST, in CAD patients (475 ± 115 vs. 365 ± 146 s, p < 0.001; and 23511 ± 4352 vs. 20583 ± 6234 bpm⋅mmHg, respectively, p = 0.01), but not in MVA patients (308 ± 160 vs. 284 ± 136 s; p = 0.19; and 21290 ± 5438 vs. 20818 ± 4286 bpm⋅mmHg, respectively, p = 0.35). In MVA patients, a significant correlation was found between heart rate at STD during N-EST and CBF response to nitroglycerin (r = 0.40, p = 0.04).

Conclusions

Short-acting nitrates improve EST results in CAD, but not in MVA patients. In MVA patients a lower nitrate-dependent coronary microvascular dilation may contribute to the lack of effects of nitrates on EST results.
Literatur
1.
Zurück zum Zitat Bugiardini R, Bairey Merz CN. Angina with “normal” coronary arteries: a changing philosophy. JAMA. 2005;293:477–84.PubMedCrossRef Bugiardini R, Bairey Merz CN. Angina with “normal” coronary arteries: a changing philosophy. JAMA. 2005;293:477–84.PubMedCrossRef
2.
Zurück zum Zitat Erbel R, Ge J, Bockisch A, et al. Value of intracoronary ultrasound and Doppler in the differentiation of angiographically normal coronary arteries: a prospective study in patients with angina pectoris. Eur Heart J. 1996;17:880–9.PubMedCrossRef Erbel R, Ge J, Bockisch A, et al. Value of intracoronary ultrasound and Doppler in the differentiation of angiographically normal coronary arteries: a prospective study in patients with angina pectoris. Eur Heart J. 1996;17:880–9.PubMedCrossRef
3.
Zurück zum Zitat Cannon RO, Epstein SE. “Microvascular angina” as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol. 1988;61:1338–43.PubMedCrossRef Cannon RO, Epstein SE. “Microvascular angina” as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol. 1988;61:1338–43.PubMedCrossRef
4.
Zurück zum Zitat Lanza GA. Cardiac syndrome X: a critical overview and future perspectives. Heart. 2007;93:159–66.PubMedCrossRef Lanza GA. Cardiac syndrome X: a critical overview and future perspectives. Heart. 2007;93:159–66.PubMedCrossRef
5.
Zurück zum Zitat Wessel TR, Arant CB, McGorray SP, et al. NHLBI Women’s Ischemia Syndrome Evaluation (WISE). Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or coronary artery disease in women evaluated for suspected ischemia: results from the NHLBI Women’s Ischemia Syndrome Evaluation (WISE). Clin Cardiol. 2007;30:69–74.PubMedCrossRef Wessel TR, Arant CB, McGorray SP, et al. NHLBI Women’s Ischemia Syndrome Evaluation (WISE). Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or coronary artery disease in women evaluated for suspected ischemia: results from the NHLBI Women’s Ischemia Syndrome Evaluation (WISE). Clin Cardiol. 2007;30:69–74.PubMedCrossRef
6.
Zurück zum Zitat Radice M, Giudici V, Marinelli G. Long-term follow-up in patients with positive exercise test and angiographically normal coronary arteries (syndrome X). Am J Cardiol. 1995;75:620–1.PubMedCrossRef Radice M, Giudici V, Marinelli G. Long-term follow-up in patients with positive exercise test and angiographically normal coronary arteries (syndrome X). Am J Cardiol. 1995;75:620–1.PubMedCrossRef
7.
Zurück zum Zitat Lanza GA, Crea F. Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management. Circulation. 2010;121:2317–25.PubMedCrossRef Lanza GA, Crea F. Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management. Circulation. 2010;121:2317–25.PubMedCrossRef
8.
Zurück zum Zitat Herrmann J, Kaski JC, Lerman A. Coronary microvascular dysfunction in the clinical setting: from mystery to reality. Eur Heart J 2012. [Epub ahead of print] Herrmann J, Kaski JC, Lerman A. Coronary microvascular dysfunction in the clinical setting: from mystery to reality. Eur Heart J 2012. [Epub ahead of print]
9.
Zurück zum Zitat Neill WA, Judkins MP, Dhindsa DS, Metcalfe J, Kassebaum G, Kloster FE. Clinically suspect ischemic heart disease not corroborated by demonstrable coronary artery disease. Physiologic investigations and clinical course. Am J Cardiol. 1972;29:171–9.PubMedCrossRef Neill WA, Judkins MP, Dhindsa DS, Metcalfe J, Kassebaum G, Kloster FE. Clinically suspect ischemic heart disease not corroborated by demonstrable coronary artery disease. Physiologic investigations and clinical course. Am J Cardiol. 1972;29:171–9.PubMedCrossRef
10.
Zurück zum Zitat Gavrielides S, Kaski JC, Galassi AR, et al. Recovery-phase patterns of ST segment depression in the heart rate domain cannot distinguish between anginal patients with coronary artery disease and patients with syndrome X. Am Heart J. 1991;122:1593–8.PubMedCrossRef Gavrielides S, Kaski JC, Galassi AR, et al. Recovery-phase patterns of ST segment depression in the heart rate domain cannot distinguish between anginal patients with coronary artery disease and patients with syndrome X. Am Heart J. 1991;122:1593–8.PubMedCrossRef
11.
Zurück zum Zitat Lanza GA, Manzoli A, Bia E, Crea F, Maseri A. Acute effects of nitrates on exercise testing in patients with syndrome X. Clinical and pathophysiological implications. Circulation. 1994;90:2695–700.PubMedCrossRef Lanza GA, Manzoli A, Bia E, Crea F, Maseri A. Acute effects of nitrates on exercise testing in patients with syndrome X. Clinical and pathophysiological implications. Circulation. 1994;90:2695–700.PubMedCrossRef
12.
Zurück zum Zitat Radice M, Giudici V, Albertini A, Mannarini A. Usefulness of changes in exercise tolerance induced by nitroglycerin in identifying patients with syndrome X. Am Heart J. 1994;127:531–5.PubMedCrossRef Radice M, Giudici V, Albertini A, Mannarini A. Usefulness of changes in exercise tolerance induced by nitroglycerin in identifying patients with syndrome X. Am Heart J. 1994;127:531–5.PubMedCrossRef
13.
Zurück zum Zitat Kaski JC. Valenzuela Garcia LF, Therapeutic options for the management of patients with cardiac syndrome X. Eur Heart J. 2001;22:283–93.PubMedCrossRef Kaski JC. Valenzuela Garcia LF, Therapeutic options for the management of patients with cardiac syndrome X. Eur Heart J. 2001;22:283–93.PubMedCrossRef
14.
Zurück zum Zitat Galiuto L, Sestito A, Barchetta S, et al. Noninvasive evaluation of flow reserve in the left anterior descending coronary artery in patients with cardiac syndrome X. Am J Cardiol. 2007;99:1378–83.PubMedCrossRef Galiuto L, Sestito A, Barchetta S, et al. Noninvasive evaluation of flow reserve in the left anterior descending coronary artery in patients with cardiac syndrome X. Am J Cardiol. 2007;99:1378–83.PubMedCrossRef
15.
Zurück zum Zitat Voci P, Pizzuto F, Mariano E, Puddu PE, Sardella G, Romeo F. Usefulness of coronary flow reserve measured by transthoracic coronary Doppler ultrasound to detect severe left anterior descending coronary artery stenosis. Am J Cardiol. 2003;92:1320–4.PubMedCrossRef Voci P, Pizzuto F, Mariano E, Puddu PE, Sardella G, Romeo F. Usefulness of coronary flow reserve measured by transthoracic coronary Doppler ultrasound to detect severe left anterior descending coronary artery stenosis. Am J Cardiol. 2003;92:1320–4.PubMedCrossRef
16.
Zurück zum Zitat Hozumi T, Yoshida K, Akasaka T, et al. Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by Doppler echocardiography. Comparison with invasive technique. J Am Coll Cardiol. 1998;32:1251–9.PubMedCrossRef Hozumi T, Yoshida K, Akasaka T, et al. Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by Doppler echocardiography. Comparison with invasive technique. J Am Coll Cardiol. 1998;32:1251–9.PubMedCrossRef
17.
Zurück zum Zitat Harrison DG, Bates JN. The nitrovasodilators: new ideas about old drugs. Circulation. 1993;87:1461–7.PubMedCrossRef Harrison DG, Bates JN. The nitrovasodilators: new ideas about old drugs. Circulation. 1993;87:1461–7.PubMedCrossRef
18.
Zurück zum Zitat Kurz MA, Lamping KG, Bates JN, Eastham CL, Marcus ML, Harrison DG. Mechanisms responsible for the heterogeneous coronary microvascular response to nitroglycerin. Circ Res. 1991;68:847–55.PubMedCrossRef Kurz MA, Lamping KG, Bates JN, Eastham CL, Marcus ML, Harrison DG. Mechanisms responsible for the heterogeneous coronary microvascular response to nitroglycerin. Circ Res. 1991;68:847–55.PubMedCrossRef
19.
Zurück zum Zitat Chirkov YY, Holmes AS, Chirkova LP, Horowitz JD. Nitrate resistance in platelets from patients with stable angina pectoris. Circulation. 1999;100:129–34.PubMedCrossRef Chirkov YY, Holmes AS, Chirkova LP, Horowitz JD. Nitrate resistance in platelets from patients with stable angina pectoris. Circulation. 1999;100:129–34.PubMedCrossRef
20.
Zurück zum Zitat Rajendran S, Chirkov YY. Platelet hyperaggregability: impaired responsiveness to nitric oxide (“platelet NO resistance”) as a therapeutic target. Cardiovasc Drugs Ther. 2008;22:193–203.PubMedCrossRef Rajendran S, Chirkov YY. Platelet hyperaggregability: impaired responsiveness to nitric oxide (“platelet NO resistance”) as a therapeutic target. Cardiovasc Drugs Ther. 2008;22:193–203.PubMedCrossRef
21.
Zurück zum Zitat Schächinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 2000;101:1899–906.PubMedCrossRef Schächinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 2000;101:1899–906.PubMedCrossRef
22.
Zurück zum Zitat Bugiardini R, Borghi A, Pozzati A, Ottani F, Morgagni GL, Puddu P. The paradox of nitrates in patients with angina pectoris and angiographically normal coronary arteries. Am J Cardiol. 1993;72:343–7.PubMedCrossRef Bugiardini R, Borghi A, Pozzati A, Ottani F, Morgagni GL, Puddu P. The paradox of nitrates in patients with angina pectoris and angiographically normal coronary arteries. Am J Cardiol. 1993;72:343–7.PubMedCrossRef
23.
Zurück zum Zitat Lanza GA, Colonna G, Pasceri V, Maseri A. Atenolol versus amlodipine versus isosorbide5-mononitrate on anginal symptoms in syndrome X. Am J Cardiol. 1999;84:854–6.PubMedCrossRef Lanza GA, Colonna G, Pasceri V, Maseri A. Atenolol versus amlodipine versus isosorbide5-mononitrate on anginal symptoms in syndrome X. Am J Cardiol. 1999;84:854–6.PubMedCrossRef
Metadaten
Titel
Lack of Effect of Nitrates on Exercise Stress Test Results in Patients with Microvascular Angina
verfasst von
Giulio Russo
Antonino Di Franco
Priscilla Lamendola
Pierpaolo Tarzia
Roberto Nerla
Alessandra Stazi
Angelo Villano
Alfonso Sestito
Gaetano A. Lanza
Filippo Crea
Publikationsdatum
01.06.2013
Verlag
Springer US
Erschienen in
Cardiovascular Drugs and Therapy / Ausgabe 3/2013
Print ISSN: 0920-3206
Elektronische ISSN: 1573-7241
DOI
https://doi.org/10.1007/s10557-013-6439-z

Weitere Artikel der Ausgabe 3/2013

Cardiovascular Drugs and Therapy 3/2013 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.